Cell therapy can become a new stage in the treatment of pathologies of the cardiovascular system. In Russia, heart disease are the top causes of mortality. Russians die from strokes and heart attacks are 2-4 times more likely than residents of Europe, USA and Canada. Nearly 23 million people have cardiovascular disease and need special treatment from doctors. This new approach may soon become a stem medicine.
Already obtained positive results in clinical studies of the action of stem cells in the cardiovascular system. Their use, say the scientists, is able to improve blood flow to the heart and reduce the risk of death from heart disease.
In experiments on laboratory animals scientists have established that stem cells reduces the severity of arrhythmias in patients with this disease. Note that while all studies are in the initial stages, in any hospital in the world to get session cell therapy does not work, too high likelihood of possible complications.